Skip to main content

Travere Therapeutics, Inc 10-K for FY2025

Travere Therapeutics, Inc. (TVTX)

10-K 2026-02-19 For: 2025-12-31
View Original
Added on April 07, 2026

About this 10-K

Travere Therapeutics, Inc filed this 10-K on February 19, 2026, covering the fiscal year ended December 31, 2025 (FY2025).

Headline figures

Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$490.73M
up 110.5% from $233.18M a year earlier
Net loss
$25.55M
compared with a net loss of $321.55M a year earlier
Diluted EPS
-$0.29
compared with -$4.08 a year earlier